Initiator Pharma A/S (INIT.ST)
SEK 7.0
(-1.41%)
SEK 7.0
(-1.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 23.41 Thousand | 38.42 Thousand | 21.62 Thousand | 9299.00 | 8366.00 | 11.43 Thousand |
| Gross Profit | -23.41 Thousand | -38.42 Thousand | -21.62 Thousand | -9299.00 | -8366.00 | -11.43 Thousand |
| Operating Expenses | 3617.00 | 3.31 Million | 1.44 Million | 1.23 Million | 973 Thousand | 1.17 Million |
| Selling, General and Administrative Expenses | 3617.00 | 3315.00 | 1435.00 | 1206.00 | 886.00 | 1085.00 |
| Research and Development Expenses | 15.29 Thousand | 26.34 Thousand | 11.8 Thousand | 5194.00 | 6259.00 | 8666.00 |
| Other Expenses | -15.29 Thousand | 3.31 Million | 1.44 Million | 1.23 Million | 973 Thousand | 1.17 Million |
| Cost and Expenses | 27.02 Thousand | 3.31 Million | 1.44 Million | 1.23 Million | 973 Thousand | 1.17 Million |
| Operating Income | -27.02 Thousand | -41.74 Million | -23.07 Million | -10.53 Million | -9.33 Million | -12.61 Million |
| Interest Expense | - | 2.39 Million | 1.17 Million | - | 636 Thousand | 93 Thousand |
| Income Tax Expense | 4834.00 | -5.67 Million | -3.18 Million | -1.54 Million | -1.68 Million | -2.4 Million |
| Earnings before Tax | -27.7 Thousand | -44.13 Million | -24.24 Million | -10.24 Million | -9.97 Million | -12.7 Million |
| Net Income | -22.87 Thousand | -38.45 Million | -21.06 Million | -8.69 Million | -8.28 Million | -10.29 Million |
| Earnings Per Share Basic | -0.00 | -0.72 | -0.53 | -0.30 | -0.32 | -0.40 |
| Earnings Per Share Diluted | -0.00 | -0.72 | -0.53 | -0.30 | -0.32 | -0.40 |
| Weighted Average Shares Outstanding | 52.41 Million | 53.22 Million | 39.68 Million | 28.99 Million | 26.12 Million | 25.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.41 Million | 53.22 Million | 39.68 Million | 28.99 Million | 26.2 Million | 25.88 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -27.02 Thousand | -41.72 Thousand | -23.06 Million | -10.5 Thousand | -9252.00 | -12.52 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 3.65 Million | 2.9 Million | 2692.00 | 23.41 Thousand | 4.5 Million | 8183.00 |
| Gross Profit | -3.65 Million | -2.9 Million | -2692.00 | -23.41 Thousand | -4.5 Million | -8183.00 |
| Operating Expenses | 1.33 Million | 676 Thousand | 1587.00 | 3617.00 | 687 Thousand | 699 Thousand |
| Selling, General and Administrative Expenses | 1.33 Million | 676 Thousand | 1587.00 | - | 687.00 | -699 Thousand |
| Research and Development Expenses | 890 Thousand | - | 668.00 | - | 3194.00 | 5586.00 |
| Other Expenses | -890 Thousand | - | - | - | - | - |
| Cost and Expenses | 4.99 Million | 3.57 Million | 4279.00 | 27.02 Thousand | 5.19 Million | 699 Thousand |
| Operating Income | -4.99 Million | -3.57 Million | -4279.00 | -27.02 Thousand | -5.19 Million | -8.88 Million |
| Interest Expense | - | - | -876 Thousand | - | - | 1.54 Million |
| Income Tax Expense | -4.99 Million | -546 Thousand | 4834.00 | 4834.00 | -5191.00 | -8882.00 |
| Earnings before Tax | -4.78 Million | -4.12 Million | -3405.00 | -27.7 Thousand | -4.61 Million | -10.42 Million |
| Net Income | -4.78 Million | -4.12 Million | 1429.00 | -22.87 Thousand | -4.61 Million | -10.42 Million |
| Earnings Per Share Basic | -0.09 | -0.08 | - | - | -0.08 | -0.18 |
| Earnings Per Share Diluted | -0.09 | -0.08 | - | - | -0.08 | -0.18 |
| Weighted Average Shares Outstanding | 56.04 Million | 52.47 Million | 57.59 Million | 52.41 Million | 56.94 Million | 56.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.04 Million | 52.47 Million | 57.59 Million | 52.41 Million | 56.94 Million | 56.94 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4.99 Million | -3.57 Million | 10.54 Thousand | - | -5.19 Million | -8.88 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CAKE
SPMTF
ALCOF
GAGV
NCEN
007700